Close Menu

This week in the Proceedings of the National Academy of Sciences, scientists at the Ludwig Institute for Cancer Research in Sao Paulo have used bioinformatics to build the human cell surfaceome. From this catalog of 3,702 cell surface transmembrane proteins, they were able to look at gene expression differences to find surfaceome genes that could be possible tumor targets, 593 of which they validated using qPCR.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Bloomberg reports AstraZeneca may conduct another study of its candidate SARS-CoV-2 vaccine after dosing error.

Moderna is applying for an Emergency Use Authorization for its coronavirus vaccine, according to the New York Times.

The National Health Service is to conduct a trial of Grail's blood-based screening test for cancer.

In PLOS this week: somatic mutation patterns of glioblastomas among Lebanese patients, phenome-wide study using UK Biobank data, and more.